In the rapidly transforming landscape of global clinical trials, the transition from traditional paper-based informed consent to Remote Patient Consent Management (eConsent) represents a paradigm shift. As a leading manufacturer, Dongguan Trial Medical Co., Ltd. is at the forefront of this digital revolution, providing OEM/ODM solutions that bridge the gap between complex regulatory requirements and patient-centric trial designs.
True eConsent isn't just about a PDF and an electronic signature. Our systems integrate multimedia education, interactive comprehension assessments, and real-time telehealth consultation capabilities. This provides a significant "information gain" for both the participant and the sponsor, ensuring that consent is truly informed, ongoing, and ethically sound according to FDA 21 CFR Part 11 and EU Annex 11 standards.
In the US and Canada, our platforms focus on HIPAA-compliant data encryption and integration with EHR systems. We support large-scale Decentralized Clinical Trials (DCT) where patients remain in rural locations while participating in top-tier research.
For the EU market, Trial Medical prioritizes data sovereignty and "The Right to be Forgotten." Our eConsent modules include localized language support for all 24 official EU languages, ensuring legal clarity across borders.
With a focus on China, Japan, and Australia, we provide infrastructure that handles diverse telecommunications standards and local linguistic nuances, facilitating cross-regional multi-center studies.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, and healthcare institutions worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, and digital research tools. These are designed to facilitate real-time data collection and improve participant engagement throughout the clinical research process.
Being based in Dongguan allows us to leverage the world's most robust electronics and medical device supply chain. This translates to:
Integration of facial recognition and fingerprint scanning to ensure the person providing consent is the verified trial participant, enhancing the "Trust" pillar of E-E-A-T.
Utilizing decentralized ledgers to create immutable records of the consent process, preventing retroactive data manipulation and ensuring absolute reliability for auditors.
Developing AI assistants that can answer patient questions in real-time during the consent process, using Natural Language Processing (NLP) to gauge patient understanding levels.
The global eConsent market is projected to grow at a CAGR of 15% through 2030. This growth is driven by the FDA's increasing acceptance of decentralized models and the necessity for remote solutions highlighted by global health challenges. Industrial leaders are moving away from siloed software toward Integrated Patient Platforms where consent, data collection, and telehealth coexist. Trial Medical's ODM services allow brands to enter this space quickly with proven, medical-grade hardware and software frameworks.
Trial Medical
